| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 1,808,006 | 1,800,306 | 1,826,603 | 1,837,901 | | Cost of Revenue | 1,053,489 | 1,040,925 | 1,073,123 | 1,083,481 | | | Gross Profit | 754,517 | 759,381 | 753,480 | 754,420 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 424,449 | 432,328 | 428,179 | 436,630 | | Non Recurring |
-
| 673 | (424) | (249) | | Others | 9,005 | 9,323 | 8,790 | 9,916 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 321,063 | 317,057 | 316,935 | 308,123 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (2,273) | (7,797) | (7,693) | (1,480) | | Earnings Before Interest And Taxes | 327,360 | 307,654 | 308,168 | 306,409 | | Interest Expense | 39,844 | 44,577 | 47,850 | 43,404 | | Income Before Tax | 287,516 | 263,077 | 260,318 | 263,005 | | Income Tax Expense | 110,189 | 93,481 | 100,642 | 100,787 | | Minority Interest |
-
| (8,221) | (8,604) | (7,826) | | | | Net Income From Continuing Ops | 177,327 | 169,596 | 159,676 | 162,218 | | | Non-recurring Events | | Discontinued Operations | (1,671) | 217 | (48,934) | (890) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 175,656 | 169,813 | 110,742 | 161,328 | | Preferred Stock And Other Adjustments | (8,554) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $167,102 | $169,813 | $110,742 | $161,328 |
|
0.45% Nasdaq 
0.20%
Income Statement
